No abstract available
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adalimumab / adverse effects
-
Adalimumab / immunology*
-
Antibodies, Anti-Idiotypic / blood*
-
Crohn Disease / blood
-
Crohn Disease / diagnosis
-
Crohn Disease / drug therapy*
-
Crohn Disease / immunology
-
Epitopes
-
HLA-DQ alpha-Chains / genetics*
-
HLA-DQ alpha-Chains / immunology
-
Haplotypes*
-
Humans
-
Infliximab / adverse effects
-
Infliximab / immunology*
-
Polymorphism, Genetic*
-
Treatment Outcome
-
Tumor Necrosis Factor Inhibitors / adverse effects
-
Tumor Necrosis Factor Inhibitors / immunology*
Substances
-
Antibodies, Anti-Idiotypic
-
Epitopes
-
HLA-DQ alpha-Chains
-
HLA-DQA1 antigen
-
Tumor Necrosis Factor Inhibitors
-
Infliximab
-
Adalimumab